Liver-type fatty acid-binding protein is highly expressed in intestinal metaplasia and in a subset of carcinomas of the stomach without association with the fatty acid synthase status in the carcinoma

Pathobiology

Volumn 71, Issue 3, 2004, Pages 115-122

  Hashimoto, Takeaki ^a   Kusakabe, Takashi ^a   Watanabe, Kazuo ^a   Sugino, Takashi ^a   Fukuda, Takeaki ^a   Nashimoto, Atsushi ^b   Honma, Kei Ichi ^b   Sato, Yukio ^a   Kimura, Hideki ^c   Fujii, Hiroshi ^d   Suzuki, Toshimitsu ^a  

^a FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^b NIIGATA CANCER CENTER HOSPITAL   (Japan)

^c UNIVERSITY OF FUKUI   (Japan)

^d NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Fatty acid synthase; Gastric adenoma; Gastric cancer; Intestinal metaplasia; Liver type fatty acid binding protein

Indexed keywords

FATTY ACID BINDING PROTEIN; FATTY ACID SYNTHASE;

ADENOMATOUS POLYP; ADULT; AGE; ARTICLE; CANCER GROWTH; CANCER TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EPITHELIUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; LIVER METASTASIS; LYMPH NODE METASTASIS; LYMPHATIC SYSTEM; MALE; PAPILLARY CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SEX DIFFERENCE; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH CARCINOMA; STOMACH GLAND; VEIN PERMEABILITY;

ADENOCARCINOMA; ADENOMA; ANTIGENS, DIFFERENTIATION; CARRIER PROTEINS; FATTY ACID SYNTHETASE COMPLEX; FATTY ACID-BINDING PROTEINS; FATTY ACIDS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; METAPLASIA; MIDDLE AGED; NEOPLASM STAGING; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 12144287302     PISSN: 10152008     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076465     Document Type: Article

References (41)

1. Bass NM: The cellular fatty acid binding proteins: Aspects of structure, regulation, and function. Int Rev Cytol 1988;111:143-184.
2. Veerkamp JH, Peeters RA, Maatman RGHJ: Structural and functional features of different types of cytoplasmic fatty acid-binding proteins. Biochim Biophys Acta 1991;1081:1-24.
3. Veerkamp J, Maatman RGHJ, Prinsen C: Fatty acid-binding proteins: Structural and functional diversity. Biochem Soc Trans 1992;20:801-805.
4. Sacchettini JC, Gordon JI: Rat intestinal fatty acid binding protein. J Biol Chem 1993;268:18399-18402.
5. Haunerland NH, Jacobson BL, Wesenberg G, Rayment I, Holden HM: Three-dimensional structure of the muscle fatty acid binding protein isolated from the desert locust Schistocerca gregaria. Biochemistry 1994;33:12378-12385.
6. Veerkamp JH, Maatman RGHJ: Cytoplasmic fatty acid-binding proteins: Their structure and genes. Prog Lipid Res 1995;34:17-52.
7. Bennett E, Stenvers KL, Lund PK, Popko B: Cloning and characterization of a cDNA encoding a novel fatty acid binding protein from rat brain. J Neurochem 1994;63:1616-1624.
8. Oko R, Morales CR: A novel testicular protein, with sequence similarities to a family of lipid binding proteins, is a major component of the rat sperm perinuclear theca. Dev Biol 1994;166:235-245.
9. Chan L, Wei C-F, Li W-H, Yang C-Y, Ratner P, Pownall H, Gotto AM Jr, Smith LC: Human liver fatty acid binding protein cDNA and amino acid sequence. Functional and evolutionary implications. J Biol Chem 1985;260:2629-2632.
10. Suzuki T, Ono T: Immunohistochemical studies on the distribution and frequency of fatty acid-binding protein positive cells in human fetal, newborn and adult liver tissues. J Pathol 1987;153:385-394.
11. Suzuki T, Hitomi M, Ono T: Immunohistochemical distribution of hepatic fatty acid-binding protein in rat and human alimentary tract. J Histochem Cytochem 1988;36:349-357.
12. Suzuki T, Ono T: Ontogeny of hepatic fatty acid-binding protein immunoreactivity in human liver and intestinal tract. Acta Pathol Jpn 1988;38:979-987.
13. Watanabe K, Hoshi N, Tsuura Y, Kanda K, Fujita M, Fujii M, Ono T, Suzuki T: Immunohistochemical distribution of intestinal 15 kDa protein in human tissues. Arch Histol Cytol 1995;58:303-306.
14. Sacchetti JC, Scapin G, Gopaul D, Gordon JI: Refinement and analysis of the structure of Escherichia coli-derived rat intestinal fatty acid-binding protein with bound oleate to 1.75 Å resolution: Correlation with the structures of apoprotein and the protein with bound palmitate. J Biol Chem 1992;267:23534-23545.
15. Richieri GV, Ogata RT, Kleinfeld AM: Equilibrium constants for the binding of fatty acids with fatty acid-binding proteins from adipocyte, intestine, heart, and liver measured with the fluorescence probe ADIFAB. J Biol Chem 1994;269:23918-23930.
16. Burrier RE, Manson CE, Brecher P: Binding of acyl-CoA to liver fatty acid binding protein: Effect on acyl-CoA synthesis. Biochim Biophys Acta 1987;919:221-230.
17. Takikawa H, Kaplowitz N: Binding of bile acids, oleic acid, and organic anions by rat and human hepatic Z protein. Arch Biochem Biophys 1986;251:385-392.
18. Thumser AEA, Voysey JE, Wilton DC: The binding of lysophospholipids to rat liver fatty acid-binding protein and albumin. Biochem J 1994;301:801-806.
19. Burrier RE, Brecher P: Binding of lysophosphatidylcholine to the rat liver fatty acid binding protein. Biochim Biophys Acta 1986;879:229-239.
20. Richieri GV, Ogata RT, Kleinfeld AM: Fatty acid interactions with native and mutant fatty acid binding proteins. Mol Cell Biochem 1999;192:77-85.
21. Richieri GV, Ogata RT, Kleinfeld AM: Thermodynamic and kinetic properties of fatty acid interactions with rat liver fatty acid-binding protein. J Biol Chem 1996;271:31068-31074.
22. Kusakabe T, Nashimoto A, Honma K, Suzuki T: Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach. Histopathology 2002;40:71-79.
23. Bressler R, Wakil SJ: Studies on the mechanism of fatty acid synthesis: The conversion of malonyl coenzyme A to long chain fatty acid. J Biol Chem 1961;236:1643-1651.
24. Wakil SJ: Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry 1989;28:4523-4530.
25. Kuhajda FP, Jenner K, Wood FD, Hennigar RA, Jacobs LB, Dick JD, Pasternack GR: Fatty acid synthesis. A potential selective target for antineoplastic therapy. Proc Natl Acad Sci USA 1994;91:6379-6383.
26. Japanese Gastric Cancer Association: Japanese Classification of Gastric Carcinoma, ed 13. Tokyo, Kanehara, 1999, pp 4-13, 22-27.
27. Takahashi K, Odani S, Ono T: Isolation and characterization of three fractions (DE-I, DEII, and DE-III) of rat-liver Z-protein and the complete primary structure of DE-II. Eur J Biochem 1983;136:589-601.
28. Kanda T, Iseki S, Hitomi M, Kimura H, Odani S, Kondo H, Matsubara Y, Muto T, Ono T: Purification and characterization of a fatty-acid-acid binding protein from the gastric mucosa of rats. Eur J Biochim 1989;185:27-33.
29. Murphy EJ, Prows DR, Jefferson JR, Schroeder F: Liver fatty acid-binding protein expression in transfected fibroblasts stimulates fatty acid uptake and metabolism. Biochim Biophys Acta 1996;1301:191-198.
30. Wolfrum C, Buhlmann C, Rolf B, Borchers T, Spener F: Variation of liver-type fatty acid binding protein content in the human hepatoma cell line HepG2 by peroxisome proliferators and antisense RNA affects the rate of fatty acid uptake. Biochim Biophys Acta 1999;1437:28-44.
31. Storch J, Thumser AEA: The fatty acid transport function of fatty acid-binding proteins. Biochim Biophys Acta 2000;1486:28-44.
32. Øtergaard M, Ramussen HH, Nielsen HV, Vorum H, Ørntoft TH, Celis JE: Protein profiling of bladder squamous cell carcinomas: Identification of markers that define their degree of differentiation. Cancer Res 1997;57:4111-4117.
33. Watanabe R, Fujii H, Yamamoto A, Hashimoto T, Kameda K, Ito M, Ono T: Immunological distribution of cutaneous fatty acid-binding protein in human skin. J Dermatol Sci 1997;16:17-22.
34. Jing C, Beesley C, Foster CS, Rudland PS, Fujii H, Ono T, Chen H, Smith PH, Ke Y: Identification of mRNA for human cutaneous fatty acid-binding protein as a metastasis-inducer. Cancer Res 2000;60:2390-2398.
35. Jing C, Beesley C, Foster CS, Chen H, Rudland PS, West DC, Fujii H, Smith PH, Ke Y: Human cutaneous fatty acid-binding protein induces metastasis by up-regulating the expression of vascular endothelial growth factor gene in rat Rama 37 model cells. Cancer Res 2001;61;4357-4364.
36. Celis JE, Ostergaard M, Basse B, Celis A, Lauridsen JB, Ratz GP, Andersen I, Hein B, Wolf H, Orntoft TF, Rasmussen HH: Loss of adipocyte-type fatty acid binding protein and other protein biomarkers is associated with progression of human bladder transitional cell carcinomas. Cancer Res 1996;56:4782-4790.
37. Hunyn HT, Larsson C, Notad S, Pollak M: Tumor suppressor activity of the gene encoding mammary-derived growth inhibitor. Cancer Res 1995;55:2225-2231.
38. Shi YE, Ni J, Xiao G, Liu YE, Fuchs A, Yu G, Su J, Cosgrove JM, Xing L, Zhang M, Li J, Aggarwal BB, Meager A, Gentz R: Antitumor activity of the novel human cancer growth inhibitor, mammary-derived growth inhibitor-related gene, MRG. Cancer Res 1997;57:3084-3091.
39. Specht B, Bartetzko N, Hohoff C, Kuhl H, Franke R, Borchers T, Spener F, et al: Mammary derived growth inhibitor is not a distinct protein but a mix of heart-type and adipocytetype fatty acid-binding protein. J Biol Chem 1996;271:19943-19949.
40. Börchers T, Hohoft C, Buhlmann C, Spener F: Heart-type fatty acid binding protein - Involvement in growth inhibition and differentiation. Prostglandins Leukot Essent Fatty Acids 1997;57:77-84.
41. Sorof S: Modulation of mitogenesis by liver fatty acid binding protein. Cancer Metastasis Rev 1994;13:317-336.